A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

Enrolling by invitation · Phase 3

Conditions studied: Systemic Lupus Erythematosus

In brief

The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.

Key facts

Study ID

NCT04976322

Run by

UCB Biopharma SRL

People needed

760

Starts

2021-07-27

Expected to finish

2030-08-07

Last updated by the study team

2026-08-07

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The participant could, in the opinion of the Investigator, benefit from long-term dapirolizumab pegol (DZP) treatment
• The participant completed one of the parent studies within 4 weeks prior to entry to this study

You may not qualify if…

• Study participant has any medical or psychiatric condition (including conditions due to neuropsychiatric systemic lupus erythematosus (SLE)) that, in the opinion of the Investigator, could jeopardize or would compromise the study participant's ability to participate in this study. This includes study participants with a life-threatening condition or ongoing malignancies at the start of the study

Where it is running

• Sl0046 50058 — Avondale, Arizona, United States
• Sl0046 50662 — Glendale, Arizona, United States
• Sl0046 50052 — Phoenix, Arizona, United States
• Sl0046 50328 — Tucson, Arizona, United States
• Sl0046 50383 — Beverly Hills, California, United States
• Sl0046 50275 — La Palma, California, United States
• Sl0046 50316 — San Leandro, California, United States
• Sl0046 50339 — Denver, Colorado, United States
• Sl0046 50239 — Brandon, Florida, United States
• Sl0046 50362 — Gainesville, Florida, United States
• Sl0046 50681 — Miami, Florida, United States
• Sl0046 50059 — Ormond Beach, Florida, United States
• Sl0046 50324 — Plantation, Florida, United States
• Sl0046 50329 — Tampa, Florida, United States
• Sl0046 50698 — Tampa, Florida, United States
• Sl0046 50368 — Atlanta, Georgia, United States
• Sl0046 50240 — Idaho Falls, Idaho, United States
• Sl0046 50474 — Hopkinsville, Kentucky, United States
• Sl0046 50285 — Lake Charles, Louisiana, United States
• Sl0046 50660 — New Orleans, Louisiana, United States
• Sl0046 50015 — Hagerstown, Maryland, United States
• Sl0046 50219 — Detroit, Michigan, United States
• Sl0046 50273 — Las Vegas, Nevada, United States
• Sl0046 50366 — Canton, New York, United States
• Sl0046 50140 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.